SST and type 2 diabetes mellitus: In contrast, a study in people with type 2 diabetes and using sodium acetoacetate infusions with and without somatostatin concluded that ketone bodies can suppress elevated hepatic glucose output independently of changes in insulin secretion, only when the concomitant stimulation of glucagon secretion is prevented.34